342 related articles for article (PubMed ID: 34312307)
1. Clinical manifestations and outcome of SARS-CoV-2 infections in children and adolescents with rheumatic musculoskeletal diseases: data from the National Paediatric Rheumatology Database in Germany.
Sengler C; Eulert S; Minden K; Niewerth M; Horneff G; Kuemmerle-Deschner J; Siemer C; Berendes R; Girschick H; Hühn R; Borte M; Hospach A; Emminger W; Armann J; Klein A; Kallinich T
RMD Open; 2021 Jul; 7(2):. PubMed ID: 34312307
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of SARS-CoV-2 infection among children and young people with pre-existing rheumatic and musculoskeletal diseases.
Kearsley-Fleet L; Chang ML; Lawson-Tovey S; Costello R; Fingerhutová Š; Švestková N; Belot A; Aeschlimann FA; Melki I; Koné-Paut I; Eulert S; Kallinich T; Berkun Y; Uziel Y; Raffeiner B; Oliveira Ramos F; Clemente D; Dackhammar C; Wulffraat NM; Waite H; Strangfeld A; Mateus EF; Machado PM; ; ; Natter M; Hyrich KL
Ann Rheum Dis; 2022 Jul; 81(7):998-1005. PubMed ID: 35338032
[TBL] [Abstract][Full Text] [Related]
3. Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry.
Machado PM; Lawson-Tovey S; Strangfeld A; Mateus EF; Hyrich KL; Gossec L; Carmona L; Rodrigues A; Raffeiner B; Duarte C; Hachulla E; Veillard E; Strakova E; Burmester GR; Yardımcı GK; Gomez-Puerta JA; Zepa J; Kearsley-Fleet L; Trefond L; Cunha M; Mosca M; Cornalba M; Soubrier M; Roux N; Brocq O; Durez P; Conway R; Goulenok T; Bijlsma JW; McInnes IB; Mariette X
Ann Rheum Dis; 2022 May; 81(5):695-709. PubMed ID: 34972811
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 infection among patients with autoinflammatory diseases: a study on 117 French patients compared with 1545 from the French RMD COVID-19 cohort: COVIMAI - the French cohort study of SARS-CoV-2 infection in patient with systemic autoinflammatory diseases.
Bourguiba R; Kyheng M; Koné-Paut I; Rouzaud D; Avouac J; Devaux M; Abdallah NA; Fautrel B; Ferreira-Maldent N; Langlois V; Ledoult E; Nielly H; Queyrel V; Sellam J; Tieulie N; Chazerain P; Evon P; Labreuche J; Savey L; Hentgen V; Grateau G; Georgin-Lavialle S;
RMD Open; 2022 May; 8(1):. PubMed ID: 35537796
[TBL] [Abstract][Full Text] [Related]
5. Clinical course and seroprevalence of COVID-19 in children with rheumatic diseases-cross-sectional study from a reference centre in Spain.
Udaondo C; Millán-Longo C; Permuy C; Valladares L; Falces-Romero I; Muñoz-Gómez C; Morales-Higuera M; Alcobendas R; Remesal A; Murias S; Calvo C
Clin Rheumatol; 2022 Jun; 41(6):1779-1784. PubMed ID: 35489011
[TBL] [Abstract][Full Text] [Related]
6. Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseases.
Hasseli R; Mueller-Ladner U; Hoyer BF; Krause A; Lorenz HM; Pfeil A; Richter J; Schäfer M; Schmeiser T; Strangfeld A; Schulze-Koops H; Voll RE; Specker C; Regierer AC
RMD Open; 2021 Jan; 7(1):. PubMed ID: 33479021
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the outcomes of SARS-CoV-2 infection in children and young people followed at Portuguese pediatric rheumatology clinics.
Melo AT; Bernardo M; Pinheiro F; Rodrigues M; Torres R; Mourão AF; Carvalho S; Nascimento J; Sousa S; Santos MJ; Soares C; Cabral M; Marques RC; Reis PC; Ramos FO
ARP Rheumatol; 2022 Oct; 1(ARP Rheumatology, nº3 2022):205-209. PubMed ID: 36056926
[TBL] [Abstract][Full Text] [Related]
8. National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD.
Hasseli R; Mueller-Ladner U; Schmeiser T; Hoyer BF; Krause A; Lorenz HM; Regierer AC; Richter JG; Strangfeld A; Voll RE; Pfeil A; Schulze-Koops H; Specker C
RMD Open; 2020 Sep; 6(2):. PubMed ID: 32878994
[TBL] [Abstract][Full Text] [Related]
9. High rates of severe disease and death due to SARS-CoV-2 infection in rheumatic disease patients treated with rituximab: a descriptive study.
Loarce-Martos J; García-Fernández A; López-Gutiérrez F; García-García V; Calvo-Sanz L; Del Bosque-Granero I; Terán-Tinedo MA; Boteanu A; Bachiller-Corral J; Vázquez-Díaz M
Rheumatol Int; 2020 Dec; 40(12):2015-2021. PubMed ID: 32945944
[TBL] [Abstract][Full Text] [Related]
10. Low frequency of disease flare in patients with rheumatic musculoskeletal diseases who received SARS-CoV-2 mRNA vaccine.
Spinelli FR; Favalli EG; Garufi C; Cornalba M; Colafrancesco S; Conti F; Caporali R
Arthritis Res Ther; 2022 Jan; 24(1):21. PubMed ID: 35016701
[TBL] [Abstract][Full Text] [Related]
11. Increased COVID-19 mortality in patients with rheumatic diseases: results from the CONTROL-19 study by the Italian Society for Rheumatology.
Zanetti A; Carrara G; Landolfi G; Rozza D; Chighizola CB; Alunno A; Andreoli L; Caporali R; Gerli R; Sebastiani GD; Valesini G; Sinigaglia L; Raffeiner B; Lomater C; Caprioli M; Fredi M; Romeo N; Cuomo G; Vadacca M; Scirè CA;
Clin Exp Rheumatol; 2022 Nov; 40(11):2038-2043. PubMed ID: 35260224
[TBL] [Abstract][Full Text] [Related]
12. Clinical characteristics and COVID-19 outcomes in a regional cohort of pediatric patients with rheumatic diseases.
Clemente D; Udaondo C; de Inocencio J; Nieto JC; Del Río PG; Fernández AG; Palomo JA; Bachiller-Corral J; Lopez Robledillo JC; Millán Longo C; Leon L; Abasolo L; Boteanu A
Pediatr Rheumatol Online J; 2021 Nov; 19(1):162. PubMed ID: 34838054
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 in rheumatic diseases in Italy: first results from the Italian registry of the Italian Society for Rheumatology (CONTROL-19).
Scirè CA; Carrara G; Zanetti A; Landolfi G; Chighizola C; Alunno A; Andreoli L; Caporali R; Gerli R; Sebastiani GD; Valesini G; Sinigaglia L;
Clin Exp Rheumatol; 2020; 38(4):748-753. PubMed ID: 32723435
[TBL] [Abstract][Full Text] [Related]
14. EULAR provisional recommendations for the management of rheumatic and musculoskeletal diseases in the context of SARS-CoV-2.
Landewé RB; Machado PM; Kroon F; Bijlsma HW; Burmester GR; Carmona L; Combe B; Galli M; Gossec L; Iagnocco A; Isaacs JD; Mariette X; McInnes I; Mueller-Ladner U; Openshaw P; Smolen JS; Stamm TA; Wiek D; Schulze-Koops H
Ann Rheum Dis; 2020 Jul; 79(7):851-858. PubMed ID: 32503854
[TBL] [Abstract][Full Text] [Related]
15. SARS-CoV-2 vaccine safety in adolescents with inflammatory rheumatic and musculoskeletal diseases and adults with juvenile idiopathic arthritis: data from the EULAR COVAX physician-reported registry.
Lawson-Tovey S; Machado PM; Strangfeld A; Mateus E; Gossec L; Carmona L; Raffeiner B; Bulina I; Clemente D; Zepa J; Rodrigues AM; Mariette X; Hyrich KL;
RMD Open; 2022 Jul; 8(2):. PubMed ID: 35908834
[TBL] [Abstract][Full Text] [Related]
16. Biological agents for rheumatic diseases in the outbreak of COVID-19: friend or foe?
Santos CS; Férnandez XC; Moriano Morales C; Álvarez ED; Álvarez Castro C; López Robles A; Pérez Sandoval T
RMD Open; 2021 Jan; 7(1):. PubMed ID: 33455920
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence and clinical outcomes of SARS-CoV-2 in paediatric patients with rheumatic disease.
Walters HM; Mian Z; Thomas L; Cerise J; Eberhard BA; Pagano E; Gottlieb BS; Steigerwald K; Hui-Yuen JS
Rheumatology (Oxford); 2022 Jun; 61(SI2):SI112-SI119. PubMed ID: 34599820
[TBL] [Abstract][Full Text] [Related]
18. Incidence of COVID-19 in a cohort of adult and paediatric patients with rheumatic diseases treated with targeted biologic and synthetic disease-modifying anti-rheumatic drugs.
Michelena X; Borrell H; López-Corbeto M; López-Lasanta M; Moreno E; Pascual-Pastor M; Erra A; Serrat M; Espartal E; Antón S; Añez GA; Caparrós-Ruiz R; Pluma A; Trallero-Araguás E; Barceló-Bru M; Almirall M; De Agustín JJ; Lladós J; Julià A; Marsal S
Semin Arthritis Rheum; 2020 Aug; 50(4):564-570. PubMed ID: 32425260
[TBL] [Abstract][Full Text] [Related]
19. Risk and prognosis of SARS-CoV-2 infection and vaccination against SARS-CoV-2 in rheumatic and musculoskeletal diseases: a systematic literature review to inform EULAR recommendations.
Kroon FPB; Najm A; Alunno A; Schoones JW; Landewé RBM; Machado PM; Navarro-Compán V
Ann Rheum Dis; 2022 Mar; 81(3):422-432. PubMed ID: 34876462
[TBL] [Abstract][Full Text] [Related]
20. Clinical features of patients with rheumatic and musculoskeletal diseases during the coronavirus disease 2019 pandemic and the association of its relapse with infection: Across-sectional study.
Zhang Y; Xu P; Huang J; Hu Z
Int J Rheum Dis; 2024 Apr; 27(4):e15150. PubMed ID: 38661306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
